Trade Arcutis Biotherapeutics, Inc. - ARQT CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.13
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.021568 %(-$0.43)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.02157%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000654 %(-$0.01)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021568 %
  (-$0.43)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000654 %
  (-$0.01)

Key Stats

• Prev. Close: 27.92
• Open: 27.49
• 1-Year Change: 88.93%
• Day's Range: 26.34 - 27.49

Trade Arcutis Biotherapeutics, Inc. - ARQT

What is Arcutis Biotherapeutics, Inc. (ARQT)?

Arcutis Biotherapeutics, Inc. is a biopharmaceutical company focused on developing treatments for dermatological conditions. Its research and development efforts concentrate on therapies for inflammatory skin diseases, including psoriasis, atopic dermatitis, and other chronic skin disorders. The company employs a pipeline of topical and systemic drug candidates designed to address the underlying causes of these conditions. Arcutis Biotherapeutics utilizes proprietary formulations and delivery technologies to improve treatment efficacy and patient adherence. It operates within the specialty pharmaceutical sector, aiming to provide novel therapeutic options for dermatology patients. The company engages in clinical development and regulatory activities to advance its product candidates. Its mission includes addressing significant unmet needs in dermatology through innovative treatment approaches.

Arcutis Biotherapeutics, Inc. Stock Price Today: Live Overview

The price today is shaped by Arcutis Biotherapeutics, Inc. as it trades at $26.8. Intraday price swings have hit $26.25 and $27.72, with a daily percentage change of -5.5476%.

FAQ: Arcutis Biotherapeutics, Inc. (ARQT)

What is the current price of ARQT stock?

The current stock price stands at $26.8.

Does ARQT pay dividends?

Arcutis Biotherapeutics, Inc. does not pay dividends.

Does ARQT have a formal corporate presence or regional headquarters in the UAE?

Arcutis Biotherapeutics, Inc. does not have an official presence in the UAE and operates via partners or distributors.

What is ARQT best known for?

The company is most famous for its dermatology-focused biopharmaceutical products.

What assets are typically shown together with ARQT?

Commonly shown alongside ARQT: UBS Group AG - CH, Expeditors, Spotify Technology SA